Liraglutide Improve Cognitive Function in Patients With Type 2 Diabetes Mellitus

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
Patients with diabetes are susceptible to dementia, but regular therapy fails to reduce the risk of dementia. In previous observational study, the investigators found that liraglutide can improve cognitive function in patients with T2DM through a metabolism-independent pathway. Here the investigators aim to further verify such effects through a randomized, controlled study.
Epistemonikos ID: 263b278ba5c7eb1bc5bafbd954a8667d66a7cad2
First added on: May 13, 2024